Øystein Kalsnes Jørstad

  • Retinal consultant; MD

Publications 2024

Jørstad ØK, Skaar S, Strand H, Røsby O, Brokstad RT, Rønning PA (2024)
Leber Hereditary Optic Neuropathy Case Report: Clinical Presentation and Treatment with Idebenone Reinforce the Evidence for m.3866T>C as a Causative Variant
Case Rep Ophthalmol, 15 (1), 513-517
DOI 10.1159/000539445, PubMed 39015230

Sauesund ES, Hertzberg SNW, Jørstad ØK, Moe MC, Erke MG, Fosmark DS, Petrovski G (2024)
A health economic pilot study comparing two diabetic retinopathy screening strategies
Sci Rep, 14 (1), 15618
DOI 10.1038/s41598-024-66405-2, PubMed 38971860

Publications 2023

Agra LLM, Sverstad A, Chagas TA, Araújo RH, Oliveira LG, Kristianslund O, Petrovski G, Maia M, Moe MC, Jørstad ØK, Melo GB (2023)
Accuracy, Precision, and Residual Volume of Commonly Used Syringes for Intravitreal Injections and the Impact on Intraocular Pressure
Ophthalmol Retina, 7 (10), 892-900
DOI 10.1016/j.oret.2023.06.003, PubMed 37302655

Husum YS, Bråten RH, Sæther EM, Moe MC, Kristiansen IS, Jørstad ØK (2023)
Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study
Acta Ophthalmol, 102 (5), 544-554
DOI 10.1111/aos.16598, PubMed 38071435

Jørstad ØK, Foss S, Gjølberg TT, Mester S, Nyquist-Andersen M, Sivertsen MS, Fossum D, Gleditsch E, Moe MC, Andersen JT (2023)
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties
Int J Retina Vitreous, 9 (1), 65
DOI 10.1186/s40942-023-00507-3, PubMed 37936232

Melo GB, Santos LA, Agra LLDM, Meyer C, Moe MC, Jørstad ØK (2023)
Accuracy and residual volume of intravitreal injection syringes in administration of very small volumes
Eye (Lond), 38 (2), 395-396
DOI 10.1038/s41433-023-02670-1, PubMed 37500753

Nilsen HY, Jørstad AL, Ryan SJ, Moe MC, Grimstad K, Aamodt AH, Holmøy T, Jørstad ØK (2023)
[A woman in her sixties who no longer recognised what she saw]
Tidsskr Nor Laegeforen, 143 (16)
DOI 10.4045/tidsskr.23.0198, PubMed 37938009

Sauesund ES, Jørstad ØK, Brunborg C, Moe MC, Erke MG, Fosmark DS, Petrovski G (2023)
A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results
Biomedicines, 11 (4)
DOI 10.3390/biomedicines11041222, PubMed 37189840

Publications 2022

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2022)
Re: Writing committee for the Post-Injection Endophthalmitis Study Group, et al.: The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections (Ophthalmology. 2021;128:1620-1626)
Ophthalmology, 129 (5), e61-e62
DOI 10.1016/j.ophtha.2022.01.017, PubMed 35232584

Blom K, Jørstad ØK, Faber RT, Stene-Johansen I, Holberg-Petersen M, Hermansen NO, Bragadóttir R (2022)
Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study
Acta Ophthalmol, 101 (1), 100-108
DOI 10.1111/aos.15207, PubMed 35751448

Eriksen KO, Wigers AR, Wedding IM, Erichsen AK, Barøy T, Søberg K, Jørstad ØK (2022)
A novel homozygous variant in the SPG7 gene presenting with childhood optic nerve atrophy
Am J Ophthalmol Case Rep, 26, 101400
DOI 10.1016/j.ajoc.2022.101400, PubMed 35243150

Faraj S, Bathen ME, Galeckas A, Myrold A, Stene-Johansen I, Jørstad ØK, Moe MC (2022)
Retinal injuries in seven teenage boys from the same handheld laser
Am J Ophthalmol Case Rep, 27, 101596
DOI 10.1016/j.ajoc.2022.101596, PubMed 35664446

Gjølberg TT, Frick R, Mester S, Foss S, Grevys A, Høydahl LS, Jørstad ØK, Schlothauer T, Sandlie I, Moe MC, Andersen JT (2022)
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
Commun Biol, 5 (1), 832
DOI 10.1038/s42003-022-03787-x, PubMed 35982144

Gjølberg TT, Lode HE, Melo GB, Mester S, Probst C, Sivertsen MS, Jørstad ØK, Andersen JT, Moe MC (2022)
A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics
Front Ophthalmol (Lausanne), 2, 882013
DOI 10.3389/fopht.2022.882013, PubMed 38983507

Hertzberg SN, Moe MC, Jørstad ØK, Petrovski BÉ, Burger E, Petrovski G (2022)
Healthcare expenditure of intravitreal anti-vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
Acta Ophthalmol, 100 (8), e1630-e1640
DOI 10.1111/aos.15151, PubMed 35467793

Hertzberg SNW, Jørstad ØK, Petrovski BÉ, Bragadottir R, Steffensen LA, Moe MC, Burger EA, Petrovski G (2022)
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective
Int J Environ Res Public Health, 19 (19)
DOI 10.3390/ijerph191912603, PubMed 36231903

Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
Idiopathic Duro-Optic Calcification
J Neuroophthalmol, 44 (1), e204
DOI 10.1097/WNO.0000000000001722, PubMed 36255093

Jacobsen HH, Jørstad ØK, Moe MC, Petrovski G, Pripp AH, Sandell T, Eide PK (2022)
Noninvasive Estimation of Pulsatile and Static Intracranial Pressure by Optical Coherence Tomography
Transl Vis Sci Technol, 11 (1), 31
DOI 10.1167/tvst.11.1.31, PubMed 35050344

Jørstad ØK, Jonsdottir TE, Ødegaard EM (2022)
[Differential treatment of one-eyed and two-eyed persons in the driving licence regulations]
Tidsskr Nor Laegeforen, 142 (4)
DOI 10.4045/tidsskr.22.0031, PubMed 35239269

Sudmann TM, Brækhus A, Jørstad ØK (2022)
[Health requirements for driving licences – on the right path with new technology]
Tidsskr Nor Laegeforen, 142 (16)
DOI 10.4045/tidsskr.22.0607, PubMed 36345625

Sudmann TM, Jonsdottir TE, Rowe FJ, Jørstad ØK (2022)
National application of the European visual field standards for driving: a survey study
BMJ Open Ophthalmol, 7 (1), e000904
DOI 10.1136/bmjophth-2021-000904, PubMed 35295687

Sverstad A, Torheim EA, Jørstad ØK (2022)
A Multi-Lumen Glaucoma Stent With Titratable Pressure-Lowering Effect: A Proof of Concept Study
Transl Vis Sci Technol, 11 (9), 20
DOI 10.1167/tvst.11.9.20, PubMed 36149647

Publications 2021

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2021)
Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis
Acta Ophthalmol, 100 (3), e859-e860
DOI 10.1111/aos.14945, PubMed 34155818

Bøhler AD, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK (2021)
Acute macular neuroretinopathy following COVID-19 vaccination
Eye (Lond), 36 (3), 644-645
DOI 10.1038/s41433-021-01610-1, PubMed 34158652

Choosing Wisely working group of the Norwegian Ophthalmological Society, Jørstad ØK, Kongsrud A, Kinge B, Fossen K, Basit S, Forsaa VA, Moe MC, Haugen OH (2021)
Choosing Wisely: recommendations from the Norwegian Ophthalmological Society
Acta Ophthalmol, 100 (6), 716
DOI 10.1111/aos.15080, PubMed 34904382

Eidet JR, Akopian M, Olstad OK, Jørstad ØK, Moe MC, Petrovski G, Pepaj M (2021)
The acute phase response protein SERPINA3 is increased in tear fluid from the unaffected eyes of patients with unilateral acute anterior uveitis
J Ophthalmic Inflamm Infect, 11 (1), 19
DOI 10.1186/s12348-021-00249-z, PubMed 34212267

Eriksen E, Jørstad ØK (2021)
[Transient smartphone blindness]
Tidsskr Nor Laegeforen, 141 (5)
DOI 10.4045/tidsskr.20.0972, PubMed 33754676

Holmøy T, Jørstad ØK (2021)
The first Norwegian doctorate in multiple sclerosis
Tidsskr Nor Laegeforen, 141 (5)
DOI 10.4045/tidsskr.20.0993, PubMed 33754679

Husum YS, Moe MC, Bragadóttir R, Jørstad ØK (2021)
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational study
Acta Ophthalmol, 99 (8), e1354-e1359
DOI 10.1111/aos.14825, PubMed 33638291

Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
Am J Ophthalmol Case Rep, 22, 101106
DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471

Jorstad OK, Sivertsen MS, Andersen JT, Moe MC (2021)
Can the ampoules of covid-19 vaccine be used better?
Tidsskr. Nor. Laegeforen., 141 (2), 110

Jørstad ØK, Jonsdottir TE, Zysset S, Rowe FJ (2021)
A traffic perimetry test that adheres to the European visual field requirements for group 2 drivers
Acta Ophthalmol, 99 (7), e1253-e1254
DOI 10.1111/aos.14742, PubMed 33421353

Jørstad ØK, Wigers AR, Marthinsen PB, Evang JA, Moe MC (2021)
The Value of Macular Optical Coherence Tomography in Watchful Waiting of Suprasellar Masses: A 2-Year Observational Study
J Neuroophthalmol, 41 (4), e516-e522
DOI 10.1097/WNO.0000000000000993, PubMed 33252889

Pihl-Jensen G, Ødegaard EM, Skogen K, Jørstad ØK, Holmøy T (2021)
A woman in her forties with unilateral blurred vision and pain upon eye movement
Tidsskr Nor Laegeforen, 141 (9)
DOI 10.4045/tidsskr.20.0932, PubMed 34107654

Sivertsen MS, Lode HE, Gjølberg TT, Petrovski G, Andersen JT, Jørstad ØK, Moe MC (2021)
Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study
BMJ Open Ophthalmol, 6 (1), e000764
DOI 10.1136/bmjophth-2021-000764, PubMed 34485702

Publications 2020

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2020)
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?
Ocul Immunol Inflamm, 30 (3), 713-716
DOI 10.1080/09273948.2020.1820530, PubMed 33026900

Eidet JR, Jørstad ØK, Fostad IG, Olstad OK, Sørland RØ, Moe MC, Petrovski G, Pepaj M (2020)
Unilateral acute anterior uveitis is associated with ipsilateral changes in the tear fluid proteome that involves the LXR/RXR pathway
J Ophthalmic Inflamm Infect, 10 (1), 13
DOI 10.1186/s12348-020-00204-4, PubMed 32458144

Eriksen KO, Jørstad ØK (2020)
Multiple Vitelliform Lesions as a Retinal Manifestation of Alport Syndrome
Case Rep Ophthalmol, 11 (1), 79-84
DOI 10.1159/000505948, PubMed 32231557

Jacobsen HH, Sandell T, Jørstad ØK, Moe MC, Ringstad G, Eide PK (2020)
In Vivo Evidence for Impaired Glymphatic Function in the Visual Pathway of Patients With Normal Pressure Hydrocephalus
Invest Ophthalmol Vis Sci, 61 (13), 24
DOI 10.1167/iovs.61.13.24, PubMed 33201186

Jonsdottir TE, Odegaard EM, Jorstad OK (2020)
Vision Tests must be adapted to the driving license requirements
Tidsskr. Nor. Laegeforen., 140 (17), 1728-1729

Jonsdottir TE, Ødegaard EM, Jørstad ØK (2020)
[The sight test must be adapted to driving licence requirements]
Tidsskr Nor Laegeforen, 140 (17)
DOI 10.4045/tidsskr.20.0777, PubMed 33231391

Jørstad ØK, Jonsdottir TE, Zysset S, Rowe F (2020)
A traffic perimetry test that adheres to the European visual field requirements
Acta Ophthalmol, 99 (4), e555-e561
DOI 10.1111/aos.14633, PubMed 32996716

Jørstad ØK, Moe MC, Eriksen K, Petrovski G, Bragadóttir R (2020)
Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology, Oslo University Hospital, Norway
Acta Ophthalmol, 98 (3), e388-e389
DOI 10.1111/aos.14426, PubMed 32227668

Jørstad ØK, Sivertsen MS, Andersen JT, Moe MC (2020)
[Can vials of COVID-19 vaccine be used more effectively?]
Tidsskr Nor Laegeforen, 140 (2)
DOI 10.4045/tidsskr.20.1039, PubMed 33528143

Publications 2019

Blom K, Jørstad ØK, Bragadóttir R (2019)
Endophthalmitis in Oslo, Norway
Acta Ophthalmol, 97 (7), 695-699
DOI 10.1111/aos.14028, PubMed 30816017

Bro T, Derebecka M, Jørstad ØK, Grzybowski A (2019)
Off-label use of bevacizumab for wet age-related macular degeneration in Europe
Graefes Arch Clin Exp Ophthalmol, 258 (3), 503-511
DOI 10.1007/s00417-019-04569-8, PubMed 31889214

Eidet JR, Biernat D, Dahlberg D, Wiedmann MKH, Jorstad OK (2019)
Foster Kennedy syndrome
Tidsskr. Nor. Laegeforen., 139 (10), 941-943

Eidet JR, Biernat D, Dahlberg D, Wiedmann MKH, Jørstad ØK (2019)
[Foster Kennedy Syndrome]
Tidsskr Nor Laegeforen, 139 (10)
DOI 10.4045/tidsskr.18.0719, PubMed 31238653

Haugo HT, Wankel VD, Bondo G, Jorstad OK (2019)
Visibility requirements for driver's license
Tidsskr. Nor. Laegeforen., 139 (1), 10-11

Innerdal C, Ekstrand JR, Wankel VD, Jørstad ØK (2019)
Visual field requirements for driving in Europe: the risk of inaccurate interpretation of visual field findings when using the binocular Esterman programme
Acta Ophthalmol, 97 (6), e939-e941
DOI 10.1111/aos.14071, PubMed 30801982

Jacobsen HH, Ringstad G, Jørstad ØK, Moe MC, Sandell T, Eide PK (2019)
The Human Visual Pathway Communicates Directly With the Subarachnoid Space
Invest Ophthalmol Vis Sci, 60 (7), 2773-2780
DOI 10.1167/iovs.19-26997, PubMed 31247084

Jelin E, Wisløff T, Jørstad ØK, Heiberg T, Moe MC (2019)
Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study
BMJ Open Ophthalmol, 4 (1), e000353
DOI 10.1136/bmjophth-2019-000353, PubMed 31673632

Jørstad ØK, Steffensen LA, Eriksen K, Bragadóttir R, Moe MC (2019)
Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway
Acta Ophthalmol, 98 (8), 774-779
DOI 10.1111/aos.14177, PubMed 31264363

Jørstad ØK, Wigers AR, Marthinsen PB, Evang JA, Moe MC (2019)
Could optical coherence tomography add to the history of the pituitary incidentaloma?
Acta Ophthalmol, 97 (8), e1157-e1158
DOI 10.1111/aos.14151, PubMed 31184420

Kristiansen IS, Haugli Bråten R, Jørstad ØK, Moe MC, Saether EM (2019)
Intravitreal therapy for retinal diseases in Norway 2011-2015
Acta Ophthalmol, 98 (3), 279-285
DOI 10.1111/aos.14262, PubMed 31587508

Lode HE, Gjølberg TT, Foss S, Sivertsen MS, Brustugun J, Andersson Y, Jørstad ØK, Moe MC, Andersen JT (2019)
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
Sci Rep, 9 (1), 18021
DOI 10.1038/s41598-019-54226-7, PubMed 31792234

Wankel VD, Bondø G, Jørstad ØK (2019)
[Wankel and colleagues respond]
Tidsskr Nor Laegeforen, 139 (1)
DOI 10.4045/tidsskr.18.0951, PubMed 30644682

Publications 2018

Jørstad ØK, Wigers AR, Marthinsen PB, Moe MC, Evang JA (2018)
Loss of horizontal macular ganglion cell complex asymmetry: an optical coherence tomography indicator of chiasmal compression
BMJ Open Ophthalmol, 3 (1), e000195
DOI 10.1136/bmjophth-2018-000195, PubMed 30519642

Jørstad ØK, Ødegaard EM, Heimdal KR, Kerty E (2018)
Leber Hereditary Optic Neuropathy Caused by a Mitochondrial DNA 10663T>C Point Mutation and Its Response to Idebenone Treatment
J Neuroophthalmol, 38 (1), 129-131
DOI 10.1097/WNO.0000000000000598, PubMed 29210930

Odegaard EM, Jorstad OK, Kerty E (2018)
A teenager with acute bilateral vision loss
Tidsskr. Nor. Laegeforen., 138 (12), 1144-1147

Sivertsen MS, Jørstad ØK, Grevys A, Foss S, Moe MC, Andersen JT (2018)
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
Sci Rep, 8 (1), 2101
DOI 10.1038/s41598-018-20525-8, PubMed 29391560

Sivertsen MS, Strøm EH, Endre KMA, Jørstad ØK (2018)
Anterior Ischemic Optic Neuropathy Due to Calciphylaxis
J Neuroophthalmol, 38 (1), 54-56
DOI 10.1097/WNO.0000000000000581, PubMed 29016409

Wankel VD, Bondo G, Jorstad OK (2018)
Vision requirements for driving licence
Tidsskr. Nor. Laegeforen., 138 (16), 1511-1512

Wankel VD, Bondø G, Jørstad ØK (2018)
[Visual requirements for driving licences]
Tidsskr Nor Laegeforen, 138 (16)
DOI 10.4045/tidsskr.18.0559, PubMed 30344329

Ødegaard EM, Jørstad ØK, Kerty E (2018)
[A teenager with acute bilateral visual loss]
Tidsskr Nor Laegeforen, 138 (12)
DOI 10.4045/tidsskr.17.0802, PubMed 30132618

Publications 2017

Jørstad ØK, Faber RT, Moe MC (2017)
Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol
Acta Ophthalmol, 95 (5), 460-463
DOI 10.1111/aos.13480, PubMed 28556485

Sand MK, Stubhaug TT, Jørstad ØK (2017)
[Atypical optic neuritis]
Tidsskr Nor Laegeforen, 137 (10), 731
DOI 10.4045/tidsskr.16.1063, PubMed 28551973

Tazmini K, Meling TR, Skattør TH, Jørstad ØK, Jørgensen AP (2017)
A woman in her 50s with chronic fatigue syndrome, sepsis and hyponatraemia
Tidsskr Nor Laegeforen, 137 (5), 372-377
DOI 10.4045/tidsskr.16.0896, PubMed 28272569

Publications 2015

Jonsdottir TE, Utheim Ø, Jørstad ØK (2015)
[Giant cell arteritis]
Tidsskr Nor Laegeforen, 135 (23-24), 2166
DOI 10.4045/tidsskr.15.0335, PubMed 26674038

Jørstad ØK, Faber RT, Moe MC (2015)
Initial improvements when converting eyes with treatment-resistant exudative AMD to aflibercept are substantially diminished after increasing treatment intervals from 4 to 8 weeks
Acta Ophthalmol, 93 (6), e510-1
DOI 10.1111/aos.12681, PubMed 25708506

Page visits: 595